The global rare inherited metabolic disorders drug market size was valued at USD 217.8 million in 2025 and is expected to reach USD 530.1 million by 2033, at a CAGR of 11.80% during the forecast period
Read MoreThe global oropharyngeal cancer market size was valued at USD 1.51 billion in 2025 and is expected to reach USD 2.17 billion by 2033, at a CAGR of 4.65% during the forecast period
Read MoreThe global myalgia market size was valued at USD 55.03 billion in 2025 and is expected to reach USD 85.09 billion by 2033, at a CAGR of 5.60% during the forecast period
Read MoreThis article explores the critical role of chemical factories in managing the synthesis of chloropivaloyl chloride, a key pharmaceutical intermediate. It covers essential strategies for storage, pre-treatment, reaction control, and environmental adaptation to ensure stability and product quality in pharmaceutical production.
Read MoreThis article examines how global chemical manufacturers control the synthesis process of tricyclohexylphosphine oxide, a critical auxiliary reagent. It explores purity control, timing, dosage optimization, and post-processing strategies essential for efficient pharmaceutical synthesis and catalyst performance.
Read More